{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000347.2:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_000347.2",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in α-synuclein"
        },
        {
          "HGVS": "NM_022143.3:c.605G>A",
          "cDNA Change": {
            "transcript": "NM_022143.3",
            "ref": "G",
            "alt": "A",
            "position": "605"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "202"
          },
          "Description in input context": "G2019S mutation in LRRK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005145"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "α-synuclein A53T and wild-type constructs were transfected into HEK293 cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000347.2:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased α-synuclein aggregation and reduced clearance in A53T-expressing cells."
        },
        {
          "Variant": "NM_022143.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "kinase activity increase",
          "Result Description": "LRRK2 G2019S showed 3-fold higher kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed for each condition."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control for aggregation assays."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector-transfected cells served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-tailed Student's t-test with p < 0.05 as significant."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Aggregation levels < 20% of wild-type, kinase activity within 1.5x wild-type range.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Aggregation levels ≥ 30% of wild-type, kinase activity ≥ 2x wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Animal Model (Drosophila)",
      "Material used": {
        "Material Source": "Animal Model",
        "Material Name": "Drosophila melanogaster",
        "Description": "Transgenic flies expressing human LRRK2 G2019S were used for behavioral and neuropathological analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_022143.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "neurodegeneration acceleration",
          "Result Description": "Flies with LRRK2 G2019S exhibited 50% shorter lifespan and severe locomotor deficits."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five independent fly lines were tested for each genotype."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates reported."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type flies were used as controls for lifespan and behavior."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Flies without transgene expression served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "1"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Kaplan-Meier survival analysis with log-rank test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lifespan ≥ 50 days, no locomotor deficits.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Lifespan < 40 days, locomotor score < 50% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}